Building and maintaining effective Key Opinion Leader (KOL) relationships can help drive successful development and commercialization of biopharmaceutical drugs and medical devices. In wake of an increasingly restricted and competitive environment, biopharmaceutical companies must optimize their KOL management structure and responsibility. The best organizational structures for KOL management must align with scientific as well as commercial perspectives.
This video provides inputs on the organizational responsibility for thought leader management, optimal structure for managing Key Opinion Leaders, transparency in engaging with KOLs and the role of Medical Affairs in Key Opinion Leader management.
This video will provide important benchmarks around the responsibility and optimal organizational structure for Thought Leader management.